Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $3.07 in the prior trading day, ImmunityBio Inc (NASDAQ: IBRX) closed at $3.13, up 1.95%. In other words, the price has increased by $1.95 from its previous closing price. On the day, 7.12 million shares were traded.
Ratios:
Our goal is to gain a better understanding of IBRX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.05 and its Current Ratio is at 2.22.
On March 06, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $8.
On January 10, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on January 10, 2025, with a $6 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 88.49.
Stock Price History:
Over the past 52 weeks, IBRX has reached a high of $7.63, while it has fallen to a 52-week low of $1.83. The 50-Day Moving Average of the stock is 17.90%, while the 200-Day Moving Average is calculated to be -7.05%.
Shares Statistics:
A total of 853.39M shares are outstanding, with a floating share count of 91.82M. Insiders hold about 89.60% of the company’s shares, while institutions hold 9.08% stake in the company.
